“…The most relevant drug combinations gathered in the current work for PAM treatment associated either (a) amphotericin B and an azole (fluconazole, ketoconazole or miconazole), with or without rifampicin (combination B PAM ), or (b) amphotericin B, azithromycin, fluconazole, or rifampicin with or without miltefosine (combination A PAM ; Table 1). 56,59–83 In the latter combination, miltefosine was associated with rifampicin in 28 cases out of 34, 60–64,70,73,76 both drugs presenting the highest EDU according to our analysis (Figure 4b). The combination A PAM , which was the closest to the one recommended by the CDC, was successful in 18% of the 34 clinical cases treated by this drug association.…”